Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT02009488 · COMPLETED
Trial details
- NCT number
- NCT02009488
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-08
- Primary completion
- 2017-01-03
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.